A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 January 2015
|
| In: |
European journal of cancer
Year: 2015, Volume: 51, Issue: 4, Pages: 522-532 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2014.12.019 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2014.12.019
|
| Author Notes: | Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, Maximilian Mehdorn, Dirk Schulz, Matthias Simon, Uwe Schlegel, Christian Senft, Karsten Geletneky, Christian Braun, Joachim G. Hartung, Dirk Reuter, Monika Warmuth Metz, Ferdinand Bach, Torsten Pietsch |
| Item Description: | Gesehen am 27.09.2016 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2014.12.019 |